These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28262021)

  • 21. Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.
    Asberom T; Zhao Z; Bara TA; Clader JW; Greenlee WJ; Hyde LA; Josien HB; Li W; McPhail AT; Nomeir AA; Parker EM; Rajagopalan M; Song L; Wong GT; Zhang L; Zhang Q; Pissarnitski DA
    Bioorg Med Chem Lett; 2007 Jan; 17(2):511-6. PubMed ID: 17079141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
    Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads.
    Rombouts FJ; Tresadern G; Delgado O; Martínez-Lamenca C; Van Gool M; García-Molina A; Alonso de Diego SA; Oehlrich D; Prokopcova H; Alonso JM; Austin N; Borghys H; Van Brandt S; Surkyn M; De Cleyn M; Vos A; Alexander R; Macdonald G; Moechars D; Gijsen H; Trabanco AA
    J Med Chem; 2015 Oct; 58(20):8216-35. PubMed ID: 26378740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs.
    Portelius E; Van Broeck B; Andreasson U; Gustavsson MK; Mercken M; Zetterberg H; Borghys H; Blennow K
    J Alzheimers Dis; 2010; 21(3):1005-12. PubMed ID: 20634579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors.
    Tresadern G; Delgado F; Delgado O; Gijsen H; Macdonald GJ; Moechars D; Rombouts F; Alexander R; Spurlino J; Van Gool M; Vega JA; Trabanco AA
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7255-60. PubMed ID: 22071305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.
    Goldstein ME; Cao Y; Fiedler T; Toyn J; Iben L; Barten DM; Pierdomenico M; Corsa J; Prasad CV; Olson RE; Li YW; Zaczek R; Albright CF
    J Pharmacol Exp Ther; 2007 Oct; 323(1):102-8. PubMed ID: 17640949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino-caprolactam derivatives as gamma-secretase inhibitors.
    Parker MF; Bronson JJ; Barten DM; Corsa JA; Du W; Felsenstein KM; Guss VL; Izzarelli D; Loo A; McElhone KE; Marcin LR; Padmanabha R; Pak R; Polson CT; Toyn JH; Varma S; Wang J; Wong V; Zheng M; Roberts SB
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5790-5. PubMed ID: 17869509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective synthesis of photoreactive peptidomimetic gamma-secretase inhibitors.
    Chun J; Yin YI; Yang G; Tarassishin L; Li YM
    J Org Chem; 2004 Oct; 69(21):7344-7. PubMed ID: 15471490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3.
    Amombo GM; Kramer T; Lo Monte F; Göring S; Fach M; Smith S; Kolb S; Schubenel R; Baumann K; Schmidt B
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7634-40. PubMed ID: 23107479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors.
    Zhao Z; Pissarnitski DA; Josien HB; Wu WL; Xu R; Li H; Clader JW; Burnett DA; Terracina G; Hyde L; Lee J; Song L; Zhang L; Parker EM
    J Med Chem; 2015 Nov; 58(22):8806-17. PubMed ID: 26496070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.
    Sun ZY; Asberom T; Bara T; Bennett C; Burnett D; Chu I; Clader J; Cohen-Williams M; Cole D; Czarniecki M; Durkin J; Gallo G; Greenlee W; Josien H; Huang X; Hyde L; Jones N; Kazakevich I; Li H; Liu X; Lee J; Maccoss M; Mandal MB; McCracken T; Nomeir A; Mazzola R; Palani A; Parker EM; Pissarnitski DA; Qin J; Song L; Terracina G; Vicarel M; Voigt J; Xu R; Zhang L; Zhang Q; Zhao Z; Zhu X; Zhu Z
    J Med Chem; 2012 Jan; 55(1):489-502. PubMed ID: 22098494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
    Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
    Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating scoring functions for docking and designing beta-secretase inhibitors.
    Katharine Holloway M; McGaughey GB; Coburn CA; Stachel SJ; Jones KG; Stanton EL; Gregro AR; Lai MT; Crouthamel MC; Pietrak BL; Munshi SK
    Bioorg Med Chem Lett; 2007 Feb; 17(3):823-7. PubMed ID: 17107793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h.
    Hussain I; Harrison DC; Hawkins J; Chapman T; Marshall I; Facci L; Ahmed S; Brackenborough K; Skaper SD; Mead TL; Smith BB; Giblin GM; Hall A; Gonzalez MI; Richardson JC
    Neurodegener Dis; 2011; 8(1-2):15-24. PubMed ID: 20689247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
    Burrell RC; Easter JA; Cassidy MP; Gillman KW; Olson RE; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2014 Aug; 57(10):600-5. PubMed ID: 25196195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study.
    Yesuvadian R; Krishnamoorthy J; Ramamoorthy A; Bhunia A
    Biochem Biophys Res Commun; 2014 May; 447(4):590-5. PubMed ID: 24747079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A practical synthesis of a gamma-secretase inhibitor.
    Scott JP; Lieberman DR; Beureux OM; Brands KM; Davies AJ; Gibson AW; Hammond DC; McWilliams CJ; Stewart GW; Wilson RD; Dolling UH
    J Org Chem; 2007 May; 72(11):4149-55. PubMed ID: 17465573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and preliminary evaluation of peptidomimetic inhibitors of human beta-secretase.
    Niu Y; Wang Y; Zou X; Yang X; Ma C; Lü Y; Zhou B; Yuan Y; Du G; Xu P
    Eur J Med Chem; 2010 May; 45(5):2089-94. PubMed ID: 20153560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of Aβ42 reduction in plasma, CSF and brain of rats treated with the γ-secretase modulator, GSM-10h.
    Hawkins J; Harrison DC; Ahmed S; Davis RP; Chapman T; Marshall I; Smith B; Mead TL; Medhurst A; Giblin GM; Hall A; Gonzalez MI; Richardson J; Hussain I
    Neurodegener Dis; 2011; 8(6):455-64. PubMed ID: 21389687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.